1. Innovative Investments
Advancing Healthcare
Annual Arab Health Dinner
2015
Annual Dinner 2015
Regional Life Sciences
Platform Update

2. KLSC is fully owned by NTEC, the technology transfer arm of the Kuwait
Investment Authority
 World’s First Sovereign Wealth Fund
 Established in 1953
 >550 bn USD in AUM
 Created by Kuwait’s Council of Ministers
 Established in 2005
 Fully owned by the KIA
 100 mn KD or ~ $350 mn paid up capital
 Five fully owned subsidiary companies:
Clean and
Alternative Energy
Investments
Life Sciences and
Healthcare
Investments
ICT and Mobile
Technology
Investments
Strategic and
Technology
Advisory Services
Human Capital
Development Solutions
and HR Services

3. From 2006 to 2009, prior to KLSC establishment, NTEC Life Sciences team
developed its relationships and cemented its strategy
The KLSC team studied and analyzed the
Life Sciences Sector in MENA…
…and developed a strategy to develop unique platforms that
would catalyze technology transfer to the region
The NTEC Life Sciences team developed strong relationships
with leading International
Industry Pioneers and Investors
Technology InvestorsTechnology Pioneers
Knowledge Transfer Platform
Pharmaceutical
Commercialization
Platform
Medical Devices
Commercialization
Platform
Industrial
(Specialty Chemicals)
Platform
Clinical
Research (CRO)
Platform
Starting in 2010, operational strategy started implementation

4. Building on the aforementioned strategy, KLSC developed five individual
platform companies to stimulate the life sciences sector in MENA
 Operational in 2010
 Fully owned by the NTEC
 15 mn KD or ~ $53 mn paid up capital
 Five platform companies in life sciences:
MENA’s leading
Contract Resource
Organization
Medical Devices and
Consumables
Distribution
MENA’s First
Life Science Focused
Training Academy
MENA’s Premiere
Active Pharmaceutical
Ingredients Producer
Leading Pharmaceutical
Licensor for the Middle
East and Africa

5. World Class Partners:
The Why?
NewBridge aims to improve the access for ‘big pharma’ companies, genomics and biologics
manufacturers to the MENA region
The How?
NewBridge pharmaceuticals is a regional specialty company providing one-stop-solution to
pharmaceuticals, biological, genomics and other innovative healthcare companies
The What?
NewBridge is the exclusive licensor of pharmaceutical products in:
Oncology Immunology Nutrition
Astral®, Aware®, Clasteon™, Halaven® Cimzia® Celia®, Delicel®,
M2PK®, Oncotype Dx®, Sancuso® RealDiet™, Taranis®
CNS Care Dermatology Metabolic Care Woman’s Health
Neupro®, Vimpat® Ebenet® Diabase® Glinconorm®, Pylera® Femmed®,Verifi®
Joe Henein, President and CEO
 Former VP & Managing Director ME/Africa - Wyeth
 Former VP & Therapeutic Area Head – Women Heath
 Former VP & Global Therapeutic Commercial Chair -
Wyeth
A leading MENA pharmaceutical licensor
Anchored in 2011 Venture Capital
Regional Footprint

6. The Why?
Innomedics aims to improve the efficiency of the healthcare system and encourage value based
medicine by providing the most efficient and best value medical equipment and consumables
The How?
Innomedics delivers innovative personalized health and mobile health products directly to the
consumers via partnerships with local pharmacy and retail distributors
The What?
Innomedics is a regional distributor of medical equipment in the GCC region that provides innovative
medical products and consumables to both government and private sector healthcare service
providers
Dr. Zahran Ahmed, Sales Director
 Total 20 years experience in medical devices distribution
 Director of Medical &Scientific Division, Al -Hajery & Sons
 Sales supervisor Bristol-myers SquibbA leading GCC focused medical devices
and consumables distribution company
Incubated in 2011 Venture Capital
Innovative Medical Products
World Class Partners and Agencies:

7. The Why?
Clinart hopes to improve the ability for big pharma companies and governments to host world-class
clinical trials in the MENA region
The How?
Clinart provides quality services with a proven track record of successful trials in the region (phase II-
IV) since 2001
The What?
Clinart MENA is a Full Service Contract Research Organization (CRO) headquartered in Dubai Health
Care City, that brings Clinical Research expertise to the Middle East region in line with local cultures
and customs
Dr. Alaa Assem, President and CEO
 20 years experience in MENA with Sandoz, Lilly, Wyeth,
Pfizer
 M.Sc in Ophthalmology from University of Alexandria
 MBA from Maastricht School of Management
(Netherlands)
Invested in 2012 Growth Capital
Experience by TherapeuticArea
World Class Partners and Clients:
Over 8,000 Patient’s Recruited for
Non-Interventional Studies
A leading MENA focused CRO

8. The Why?
LSA aims to develop healthcare professionals knowledge, practice, and clinical outcome
LSA believes in transforming healthcare leaders to advance the system & inspire change
The How?
LSA has prestigious affiliations with international top ranked medical universities to provide state-
of-the-art training programs which are accredited and recognized for its value & impact
LSA also collaborates with regional & local experts to share latest practices in their field
The What?
Unique platform for Continuous Professional Development (CPD) programs, Continuous Medical
Education (CME), and Evidence-based Professional Development (EPD)
In 2014, LSA has offered +70 various training programs to +700 participants
In 2015, LSA plans to conduct 85 programs and opens its training facility in March 2015
First Healthcare Training App in GCC
Ph. Mohammad Nahis Al Anzi, CEO
 Former COO at Kuwait Life Sciences Company
 MBA, Maastricht School of Management,
 B.Sc, Pharmacy, University of Sunderland
 Certified Professional Coach, ICF
The First Healthcare Academy in the GCC
Incubated in 2013 Venture Capital
World Class Partners:

9. The Why?
eCore aims to improve access for pharmaceutical manufacturers to best in class APIs at a
reasonable value proposition
The How?
eCore is focused on commercial and representation services in the field of industrial chemicals for
the Middle East and Africa region, across multiple industries including Food, Feed,
Pharmaceuticals, Paints, and home care
The What?
eCore is involved in:
Representation services - for reputable suppliers to develop their business in the MENA market
Importation and Distribution services
Exportation services - to support local MENA companies in identifying new export opportunities
for their products
Eng. Wael Gaama, CEO
 30 years of experience in API industry with Ciba-Geigy,
Rhone, Poulenc/Rhodia
 MBA, Ecole des HEC - Universite de Lausanne
 BS, Faculty of Engineering - University of AlexandriaMENA’s Premiere Manufacturer of
Active Pharmaceutical Ingredients (APIs)
Added in 2014 Growth Capital + Exit for Existing Partner
A Diversified Echelon of Clients Across Multiple Industries:
Regional Footprint

10. KLSC is also an investor in multiple healthcare and life science funds
and companies across the world
Investment Location Description
“KLSC invests between 3 to 5 mn USD for Significant Minority Shares in Revenue generating
companies that are ideally looking for a commercial partner for MENA”
 LP in Burrill Life Sciences Capital Fund III
 300 mn USD fund focused on life sciences
 Investments include: Acusphere, Ceptanis, Gevo, Taiwan Liposome,
Neos Therapeutics, Nevotech, Nova Therapeutics, OcooGenex, Novadaq
Technologies,Vividia, Waterstone Pharmaceuticals, Wellpartner Inc.
 LP in WP Venture IV Life Science Fund
 100 mn USD fund focused on life sciences
 Investments include: Genticel, Middle Peak, Immatics, Neuway Pharma,
Rigontec, Definiens, ImevaX
San Francisco, USA
Germany
Birmingham, UK
Indirect(Funds)Direct
Aix-en-Provence, France
 Quanta is focused on the development and commercialisation of a novel
cartridge-based haemodialysis system named SC+
 SC+ is the only high performance, portable, compact haemodialysis system
with the clinical efficacy and high flow rates of traditional in-centre machines
 The only ultrasound system with an UltraFast™ platform
 This SuperSonic speed enables innovations such as ShearWave™
Elastography and UltraFast™ Doppler while rendering clinically detailed
B-mode image quality for all clinical applications
Valbonne, France  Provides advanced medical imaging products and services for
diagnosing and monitoring cancer patients in both routine clinical
practice and clinical drug development

11. Innovative Investments
Advancing Healthcare
THANK YOU
KIPCO Tower, 27th Floor, Al Shuhadaa St., Sharq
P.O. Box 25363, Safat 13114, Kuwait
Tel : +965 22215622
Fax: +965 2249 0959
www.klsc.com.kw
Thank you and Enjoy the Dinner